| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |